HDM-8421034

N/A

Report date: 2022/11/05 17:26:52

Base Information

Drug NameHDM-8421034
Drug Alias NameHDM-8421034
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHBsAg inhibitors
TargetsHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesChina Israel Hyde Artificial Intelligence Drug Research And Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChina Israel Hyde Artificial Intelligence Drug Research And Development Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A